Key facts
- This page summarizes Jill Mullan's Form 4 filing for iSpecimen Inc. (ISPC).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Jan 2023, 15:04.
Jill Mullan - 17 Jan 2023 Form 4 Insider Report for iSpecimen Inc. (ISPC)
- Reporting relationship
- Director
- Issuer ticker
- ISPC
- Reported as of
- 17 Jan 2023
- Net transaction value
- +$66,637
- SEC form
- 4
- Accepted by SEC
- 19 Jan 2023, 15:04:53 UTC
- Prior SEC filing
- 19 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jill Mullan
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jill Mullan filed Form 4 for iSpecimen Inc. (ISPC) on 19 Jan 2023.
Change
- Previous filing in this sequence was filed on 19 Jan 2023.
- Current net transaction value: +$66,637.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ISPC
transaction
Common Stock
Options Exercise
- Transaction value
- $66,637
- Shares
- +66,637
- Change %
- +37%
- Price
- $1.00
- Shares after
- 246,226
- Date
- 17 Jan 2023
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ISPC
transaction
Derivative
Option
Options Exercise
- Transaction value
- $0
- Shares
- -66,637
- Change %
- -87%
- Price
- $0.000000
- Shares after
- 10,000
- Date
- 17 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 66,637
- Exercise price
- $1.00
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options.
Footnote F2
Represents the $1.00 exercise price per share of the stock options exercised, which was paid by the Reporting Person upon exercise of such stock options.
Footnote F3
Represents the stock options that were vested on the date of termination of employment of the Reporting Person and will expire if not exercised by the Reporting Person before January 22, 2023.
Footnote F4
Represents remaining granted stock options across all grants.